This artIcle from CANCERactive is about Pharmaceutical firm Takeda. They have been fined $6 billion for covering up increased risks of bladder cancer associated with type-2 diabetes drug ACTOS. And Takeda’s partner Eli Lilly was fined $3 billion too.
Read more about Takeda and Eli Lilly being fined for ACTOS in CANCERactive latest news
Our sites contains several other studies expressing concern over cancer risks from drugs.
